JP2012500194A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500194A5
JP2012500194A5 JP2011522551A JP2011522551A JP2012500194A5 JP 2012500194 A5 JP2012500194 A5 JP 2012500194A5 JP 2011522551 A JP2011522551 A JP 2011522551A JP 2011522551 A JP2011522551 A JP 2011522551A JP 2012500194 A5 JP2012500194 A5 JP 2012500194A5
Authority
JP
Japan
Prior art keywords
polypeptide
protein
peptide
allergen
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011522551A
Other languages
English (en)
Japanese (ja)
Other versions
JP5705113B2 (ja
JP2012500194A (ja
Filing date
Publication date
Priority claimed from PCT/GB2008/002779 external-priority patent/WO2009022155A2/en
Priority claimed from GB0814986A external-priority patent/GB0814986D0/en
Priority claimed from GB0815218A external-priority patent/GB0815218D0/en
Priority claimed from GBGB0901927.4A external-priority patent/GB0901927D0/en
Priority claimed from EP09251252.4A external-priority patent/EP2153841B2/en
Priority claimed from GB0912578A external-priority patent/GB0912578D0/en
Application filed filed Critical
Priority claimed from PCT/GB2009/001995 external-priority patent/WO2010018384A1/en
Publication of JP2012500194A publication Critical patent/JP2012500194A/ja
Publication of JP2012500194A5 publication Critical patent/JP2012500194A5/ja
Publication of JP5705113B2 publication Critical patent/JP5705113B2/ja
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011522551A 2008-08-15 2009-08-14 Ｉｌ−１０産生の刺激のためのアレルゲン由来のｔ細胞抗原 Expired - Fee Related JP5705113B2 (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
PCT/GB2008/002779 WO2009022155A2 (en) 2007-08-15 2008-08-15 Peptide with reduced dimer formation
GBPCT/GB08/002779 2008-08-15
GBPCT/GB08/002778 2008-08-15
GBPCT/GB08/002780 2008-08-15
GBPCT/GB08/002781 2008-08-15
GB0814986.6 2008-08-15
PCT/GB2008/002781 WO2009022157A2 (en) 2007-08-15 2008-08-15 Peptide with improved solubility
PCT/GB2008/002780 WO2009022156A2 (en) 2007-08-15 2008-08-15 Peptides for desensibilization against allergens
GB0814986A GB0814986D0 (en) 2008-08-15 2008-08-15 Peptide for il10 production
PCT/GB2008/002778 WO2009022154A2 (en) 2007-08-15 2008-08-15 Peptide with multiple epitopes
GB0815218A GB0815218D0 (en) 2008-08-20 2008-08-20 Ragweed peptides for vaccine
GB0815218.3 2008-08-20
GBGB0901927.4A GB0901927D0 (en) 2009-02-05 2009-02-05 Peptide for IL10 production
GB0901927.4 2009-02-05
EP09251252.4 2009-05-01
EP09251252.4A EP2153841B2 (en) 2008-08-15 2009-05-01 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
GB0912578.2 2009-07-20
GB0912578A GB0912578D0 (en) 2009-07-20 2009-07-20 Peptide for IL-10 production
PCT/GB2009/001995 WO2010018384A1 (en) 2008-08-15 2009-08-14 T-cell antigen peptide from allergen for stimulation of il-10 production

Publications (3)

Publication Number Publication Date
JP2012500194A JP2012500194A (ja) 2012-01-05
JP2012500194A5 true JP2012500194A5 (enExample) 2012-10-04
JP5705113B2 JP5705113B2 (ja) 2015-04-22

Family

ID=41112622

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011522551A Expired - Fee Related JP5705113B2 (ja) 2008-08-15 2009-08-14 Ｉｌ−１０産生の刺激のためのアレルゲン由来のｔ細胞抗原

Country Status (4)

Country Link
US (2) US8821887B2 (enExample)
EP (1) EP2331124A1 (enExample)
JP (1) JP5705113B2 (enExample)
WO (1) WO2010018384A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2393830B8 (en) 2009-02-05 2015-03-18 Circassia Limited Grass peptides for vaccine
GB201002559D0 (en) 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
AU2012249540B2 (en) 2011-04-29 2017-07-13 Selecta Biosciences, Inc. Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
CA2843274A1 (en) 2011-07-29 2013-02-07 Selecta Biosciences, Inc. Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
GB201209862D0 (en) * 2012-06-01 2012-07-18 Circassia Ltd Cladosporium peptides
CN105120894B (zh) 2012-10-30 2019-02-15 阿拉沃克斯有限公司 新颖的免疫治疗分子和其用途
EP2991646B1 (en) 2013-05-03 2020-10-07 Selecta Biosciences, Inc. Methods and compositions for enhancing cd4+ regulatory t cells
BR112016006813A2 (pt) 2013-09-25 2017-09-19 Aravax Pty Ltd Composição imunoterapêutica nova e seus usos
WO2015100360A1 (en) 2013-12-23 2015-07-02 Alk-Abelló A/S Peptide combinations and uses thereof in treating dust mite allergy
EP3189147A1 (en) 2014-09-07 2017-07-12 Selecta Biosciences, Inc. Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses
KR20170126001A (ko) * 2015-03-30 2017-11-15 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 면역용 펩티드, 면역용 펩티드의 제조 방법, 그것을 포함하는 면역 질환용 의약 조성물, 및 면역 질환의 치료 방법
EP3592389B1 (en) 2017-03-11 2025-05-07 Cartesian Therapeutics, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
EP4047007B1 (en) * 2019-10-18 2024-06-05 Pell Bio-Med Technology Co., Ltd. Peptide and use thereof in preparation of drug for treating inflammatory diseases and pain

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990011293A1 (en) 1989-03-17 1990-10-04 Immulogic Pharmaceutical Corporation Allergenic proteins from ragweed and uses therefor
US5776761A (en) * 1989-03-17 1998-07-07 Immulogic Pharmaceutical Corporation Nucleic acids encoding allergenic proteins from ragweed
WO1992004445A1 (en) * 1990-09-11 1992-03-19 The Western Australian Research Institute For Child Health Ltd. Cloning and sequencing of allergens of dermatophagoides (house dust mite)
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
JPH07502890A (ja) * 1991-10-16 1995-03-30 イミユロジク・フアーマシユーチカル・コーポレーシヨン ダーマトファゴイデス（Ｄｅｒｍａｔｏｐｈａｇｏｉｄｅｓ）（家ほこりダニ）からの主要なアレルゲンのＴ細胞エピトープ
US6441157B1 (en) * 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
WO1993021321A2 (en) 1992-04-09 1993-10-28 Immulogic Pharmaceutical Corporation T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA)
DE69333979T2 (de) * 1993-04-14 2006-12-21 Heska Corp.(n.d.Ges, d.Staates Delaware), Loveland T-zell epitope der hauptallergene von dermatophagoides (hausstaubmilbe)
US5968526A (en) * 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
CA2187329C (en) 1994-04-14 2008-07-08 Xian Chen Pharmaceutical formulations for treating dust mite allergy
US7112333B1 (en) * 1994-08-05 2006-09-26 Heska Corporation T cell epitopes of ryegrass pollen allergen
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
WO1996013589A1 (en) 1994-10-27 1996-05-09 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
WO1999034826A1 (en) 1998-01-09 1999-07-15 Circassia Limited Methods and compositions for desensitisation
US6989146B2 (en) * 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
GB0108752D0 (en) 2001-04-06 2001-05-30 Isis Innovation Peptide epitopes and uses thereof
ES2316632T3 (es) * 2001-12-05 2009-04-16 Circassia Limited Metodos y sistemas inmunoterapeuticos.
AUPS148202A0 (en) 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
WO2003088997A2 (en) 2002-04-22 2003-10-30 Universiteit Utrecht Holding B.V. Reduction of unwanted immune reactions
GB0210741D0 (en) 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
FR2841906B1 (fr) 2002-07-05 2006-08-18 Stallergenes Sa Molecule d'acide nucleique codant une preproproteine d'allergene d'un acarien du genre dermatophagoides ou euroglyphus et son utilisation pour la production dudit allergene dans les plantes
GB0308988D0 (en) 2003-04-17 2003-05-28 Univ Singapore Molecule
WO2006075253A2 (en) 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
WO2006132607A1 (en) 2005-06-10 2006-12-14 National University Of Singapore Mutant allergen(s)
US20070092532A1 (en) * 2005-10-25 2007-04-26 Board Of Trustees Operating Michigan State University Arthritis vaccines and methods
EP3097924B1 (en) 2005-11-29 2020-01-08 Intrexon Actobiotics NV Induction of mucosal tolerance to gliadin
EP1958645A1 (en) * 2007-02-13 2008-08-20 Biomay AG Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof
ES2425486T3 (es) 2007-05-09 2013-10-15 Circassia Limited Análisis de pronóstico para determinar la respuesta de células T a antígenos HLA y uso del mismo en el campo del trasplante de tejidos
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
SI2083856T1 (sl) 2007-08-15 2011-02-28 Circassia Ltd Peptidi za desenzibilizacijo proti alergijam
EP2042193A1 (en) 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
EP2433639A3 (en) * 2008-08-15 2012-06-27 Circassia Limited Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy

Similar Documents

Publication Publication Date Title
JP2012500194A5 (enExample)
CN102227214B (zh) 二聚体形成减少的组合物
JP5755398B2 (ja) 伸長されたｇｌｐ−１化合物
ES2532116T3 (es) Péptidos derivados con A-B-C-D y sus usos terapéuticos
US20230073594A1 (en) Lactoferrin compositions and methods for modulation of t cell subtypes and treatment of autoimmune diseases
Windeløv et al. Why is it so difficult to measure glucagon-like peptide-1 in a mouse?
Virtanen et al. Mammalian lipocalin allergens–insights into their enigmatic allergenicity
JP5209463B2 (ja) アシル化ｇｌｐ−１化合物
AU2009248041B2 (en) Long-acting Y2 and/or Y4 receptor agonists
JP2010536333A5 (enExample)
US8821887B2 (en) T-cell antigen peptide from allergen for stimulation of IL-10 production
US20190070287A1 (en) Tolerance therapeutic for treating polypeptide induced immune activation
US20120231999A1 (en) Peptidic glp-2 agonists
PT2059256T (pt) Péptidos imunogénicos e a sua utilização em distúrbios imunológicos
US20150141336A1 (en) Pancreatic Peptide Compounds and Use
HRP20120206T4 (hr) Cjepivo koje sadrži amb a 1 peptide za uporabu u lijeäśenju alergije na ambroziju
RS57152B1 (sr) Mimetici kalcitonina za lečenje bolesti i poremećaja
JP2013519717A5 (enExample)
JP2012516693A5 (enExample)
KR20190017017A (ko) 프로테아제-내성 모노-지질화된 펩타이드
MA32770B1 (fr) Anticorps anti-peptides igf-1/e humain modifie
WO2024098216A1 (en) Vaccine for treating allergies
FR2744123A1 (fr) Molecules biologiquement actives plus particulierement peptidiques ayant un effet potentialisateur de l'activite biologique de l'hormone de croissance
US20250388638A1 (en) Compositions and methods for oral delivery
JP2007512812A (ja) 羊膜由来ペプチドおよびその使用